A homogeneous fluorescent cell-based assay for detection of heterologously expressed nitric oxide synthase activity |
| |
Authors: | Wood Michael W Hastings Richard C Sygowski Linda A |
| |
Affiliation: | AstraZeneca R&D Wilmington, DE 19850, USA. michael.wood@astrazeneca.com |
| |
Abstract: | Arhodamine-derived, membrane-permeable fluorophore (DAR-4M AM) sensitive to nitric oxide production has been developed recently. The authors evaluated this reagent in both 96 and 384-well formats using heterologously expressed neuronal nitric oxide synthase (nNOS). nNOS transfected into HEK-293T cells was stimulated by the addition of ionomycin. The calcium mobilization resulting from ionomycin treatment of nNOS-expressing 293T cells induced a robust increase in emission intensity, as measured using a standard rhodamine filter set. The effect was time dependent, and a 3 to 4-fold stimulation could be achieved in a 2-h time period. Ionomycin-dependent nitric oxide (NO) production was completely inhibited by several arginine analogs at micromolar concentrations (e.g., L-NAME IC 50=3.0 micro M). Several arginine analog inhibitors of nNOS were revealed to be differentially reversible over increasing substrate concentrations. The assay is a facile method for characterizing inhibitors of nNOS in a relatively unperturbed cell environment. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|